Please view the Exhibitor & Sponsor Prospectus below for more details. To apply as a Sponsor and/or Exhibitor, please download the Application form to the right, and return the completed application by email to Joan Oefner at email@example.com. TO COMPLETE THE APPLICATION FORM ONLINE PLEASE FIRST DOWNLOAD THE FORM TO THE RIGHT TO YOUR COMPUTER, THEN THE FORM CAN BE FILLED IN ONLINE AND DIGITALLY SIGNED BEFORE RETURNING BY EMAIL. All items are on a space available bases. Once requests have been confirmed, a confirmation letter and invoice will be sent. For more information, please contact Joan Oefner.Download Application
SPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION
The Symposium is sponsored by the Sentinel Node Oncology Foundation (SNOF) who’s mission is to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. It is now known that the same type of cancer is different from one person to the other. After decades of research, we are poised to enter a new era of medical practice where detailed genetic and other molecular information about a patient’s cancer is routinely used to deploy effective, patient-specific remedies to treat it. We are about to enter the era of precision medicine (NCI and NIH Precision Medicine Initiative®).
This CME accredited program was developed to provide a forum for discussing and presenting pre-clinical, translational and clinical research and thereby improve understanding, diagnosis, treatment, and quality of life of patients suffering from cancer as well as explore emerging diagnostic tools and patient-specific treatments for cancer. Recent developments in understanding the cancer microenvironment and the molecular mechanisms involved in the progression of cancer cells to metastasis will be discussed. Participants will acquire knowledge on cutting edge lymphatic system imaging (including sentinel node imaging), lymph/hemangiogenesis, lymphocyte trafficking and late-breaking immunomodulation approaches and the latest innovations in molecular imaging of cancer metastasis. Studies of biomarkers and their diagnostic and prognostic applications in cancer progression and metastatic cancer, as well as their usefulness in radio imaging and molecular targeted therapy will also be significant parts of the Symposium. Promising results of recent clinical trials of emerging therapies including targeted therapy and checkpoint inhibition will be reviewed. Lymphedema, a significant complication of cancer treatment, will be addressed and the current treatment of lymphedema will be updated.
Target Audience: Based on the attendance history we anticipate 350-400 participants, a collegial atmosphere with ample opportunity to network and meet with every attendee with a potential interest in your product or services. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, hematology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training, regulatory or from industry.
Virtual Meeting: Most of the Live Presentations will be captured on video with the slide presentations synchronized in a side by side format to be accessible on the cancermetastasis.org website following the live meeting.
Please review the program and the information in this prospectus and contact Joan Oefner to discuss your participation. We are happy to customize a sponsorship package based on your company’s specific needs and requirements. Join us as an Exhibitor and/or Sponsor for Cancer Metastasis 2017!
EXHIBIT SPACE: (SPACE IS LIMITED TO 18 TABLETOPS)
EXHIBITS INCLUDE ONE 6 foot X 30 inch DRAPED TABLE WITH TWO CHAIRS, Devoted page on cancermetastasis.org and Wi-Fi.
Setup of exhibits is on Wednesday, April 19, 2017 from 6:00 – 10:00 PM and Thursday from 6:00 – 7:30 AM. Opening for the Industry Sponsored Breakfast Session on Thursday, April 20, 2017, the Exhibits will be open throughout the conference, with peak times during all coffee breaks as well as the Thursday evening e-Poster Session Reception and e-Poster sessions. Industry Sponsored Breakfast & Lunch Sessions will also take place in the Exhibit Ballroom.
Exhibit Hall Hours:
Thursday, April 20, 2017: 7:30 AM – 7:30 PM
Friday, April 21, 2017: 7:30 AM – 7:00 PM
Saturday, April 22, 2017: 7:30 AM – 2:30 PM
All sponsored breakfast and lunch sessions as well as 18 tabletop exhibits, coffee breaks, poster reception and e-Posters will be held in the 5,400 square foot Gold Rush Ballroom and its foyer. The CME Sessions as well as the Immuno-oncology CRO Prespective and the Industry – Regulatory – Academic Town Hall Non-CME Educational Sessions will be held directly above the Gold Rush Ballroom in the 5,600 square foot Emerald Ballroom.
SINGLE SUPPORT OPPORTUNITIES:
Special for LE Companies: SUPPORT FOR THE SATURDAY ONLY PATIENT SUMMIT AND LYMPHEDEMA SESSION LE SESSION SUPPORT
Along with other benefits of associating with this premier academic conference that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment & survival, all supporting companies will receive a dedicated page on www.cancermetastasis.org, to include information such as:
(not applicable for Tote Bag Insert Item)
Please contact Joan Oefner at firstname.lastname@example.org to discuss your ideas for a customized support package that would best fit the needs of your company. The Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium is sponsored by the Sentinel Node Oncology Foundation which is incorporated as a 501 (c) (3) non-profit organization. The Tax ID number of the Sentinel Node Oncology Foundation is 20-0173930.